Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends
Ammonia is central to the pathophysiology of hepatic encephalopathy (HE) in cirrhosis. Serum ammonia levels have prognostic value and have been implicated in sarcopenia, hepatotoxicity, and immune dysfunction. Studies indicate that clinicians frequently order serum ammonia levels in decompensated ci...
Gespeichert in:
Veröffentlicht in: | Clinical therapeutics 2022-03, Vol.44 (3), p.e45-e57 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e57 |
---|---|
container_issue | 3 |
container_start_page | e45 |
container_title | Clinical therapeutics |
container_volume | 44 |
creator | Deutsch-Link, Sasha Moon, Andrew M. Jiang, Yue Barritt, A. Sidney Tapper, Elliot B. |
description | Ammonia is central to the pathophysiology of hepatic encephalopathy (HE) in cirrhosis. Serum ammonia levels have prognostic value and have been implicated in sarcopenia, hepatotoxicity, and immune dysfunction. Studies indicate that clinicians frequently order serum ammonia levels in decompensated cirrhosis; however, the clinical utility of serum ammonia levels has been questioned, citing challenges in accurate measurement and interpretation. This article involves a primary review of the literature to evaluate the importance of serum ammonia in cirrhosis and examines the clinical utility of serum ammonia levels in the management of HE. In addition to the review, we conducted primary research using national claims data to investigate national trends in practitioner use of serum ammonia.
We identified all hospitalizations in a national commercial claims database with and without ammonia testing among adults with noncirrhotic chronic liver disease and cirrhosis from January 1, 2007, to September 31, 2015. We calculated the proportion of hospitalizations with ammonia testing and the number of ammonia tests per 1000 hospital-days.
Proportion of hospitalizations with ammonia testing and ammonia tests per 1000 inpatient-days increased significantly from 2007 to 2015, and particularly in 2014 and 2015, for all groups.
A review of the literature indicated that elevated serum ammonia contributes to neurotoxicity, sarcopenia, and immune dysfunction in cirrhosis. However, serum ammonia testing has not had consistent benefit in clinical diagnosis or management of HE in cirrhosis. Claims data indicated that ammonia testing increased substantially during the study period, particularly after the advent of electronic medical record systems. The rapid increase in testing may suggest that electronic health records play a crucial role in test volume by facilitating easy ordering and could be leveraged to improved value-based serum ammonia ordering. Serum ammonia levels may also benefit from standardized guidelines on collection, laboratory analysis, and interpretation. |
doi_str_mv | 10.1016/j.clinthera.2022.01.008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9050925</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S014929182200011X</els_id><sourcerecordid>2653257081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-4d4a4149dee55d9034ef2576d0528f4dea56ec43e751495d6af5fc64b2c5d5783</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EokvhK4AlLhyaYDtx_nBAWq0KrVTBga3EzXLtSXdWib3YSaX99nW0y6rlgnyw5PnNvDd-hHzgLOeMV5-3uenRjRsIOhdMiJzxnLHmBVnwpm4zzsvfL8mC8bLNRMubM_Imxi1jrGileE3OCsmFFLxeEPcLwjTQ5TB4h5qioysMYeMjxi90lTTQ6J5eDzttRuo7erXfJc2ZhgH1Bb0dscdxP5fWEEd09xdUO0t_6BG9S63HV7oO4Gx8S151uo_w7nifk9tvl-vVVXbz8_v1anmTGcmKMSttqctk3gJIaVtWlNAJWVeWSdF0pQUtKzBlAbVMlLSV7mRnqvJOGGll3RTn5Oth7m66G8AacGPQvdoFHHTYK69RPa843Kh7_6BaJlkrZBrw6Tgg-D9T2kENGA30vXbgp6hElY6oWTNrffwH3foppN1nShbJN2t4ouoDZYKPMUB3MsOZmjNVW3XKVM2ZKsZVyjR1vn-6y6nvb4gJWB4ASD_6gBBUNAjOgMUAZlTW439FHgF4IrhH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2653257081</pqid></control><display><type>article</type><title>Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Deutsch-Link, Sasha ; Moon, Andrew M. ; Jiang, Yue ; Barritt, A. Sidney ; Tapper, Elliot B.</creator><creatorcontrib>Deutsch-Link, Sasha ; Moon, Andrew M. ; Jiang, Yue ; Barritt, A. Sidney ; Tapper, Elliot B.</creatorcontrib><description>Ammonia is central to the pathophysiology of hepatic encephalopathy (HE) in cirrhosis. Serum ammonia levels have prognostic value and have been implicated in sarcopenia, hepatotoxicity, and immune dysfunction. Studies indicate that clinicians frequently order serum ammonia levels in decompensated cirrhosis; however, the clinical utility of serum ammonia levels has been questioned, citing challenges in accurate measurement and interpretation. This article involves a primary review of the literature to evaluate the importance of serum ammonia in cirrhosis and examines the clinical utility of serum ammonia levels in the management of HE. In addition to the review, we conducted primary research using national claims data to investigate national trends in practitioner use of serum ammonia.
We identified all hospitalizations in a national commercial claims database with and without ammonia testing among adults with noncirrhotic chronic liver disease and cirrhosis from January 1, 2007, to September 31, 2015. We calculated the proportion of hospitalizations with ammonia testing and the number of ammonia tests per 1000 hospital-days.
Proportion of hospitalizations with ammonia testing and ammonia tests per 1000 inpatient-days increased significantly from 2007 to 2015, and particularly in 2014 and 2015, for all groups.
A review of the literature indicated that elevated serum ammonia contributes to neurotoxicity, sarcopenia, and immune dysfunction in cirrhosis. However, serum ammonia testing has not had consistent benefit in clinical diagnosis or management of HE in cirrhosis. Claims data indicated that ammonia testing increased substantially during the study period, particularly after the advent of electronic medical record systems. The rapid increase in testing may suggest that electronic health records play a crucial role in test volume by facilitating easy ordering and could be leveraged to improved value-based serum ammonia ordering. Serum ammonia levels may also benefit from standardized guidelines on collection, laboratory analysis, and interpretation.</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2022.01.008</identifier><identifier>PMID: 35125217</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Amino acids ; Ammonia ; Ammonia - analysis ; Animal cognition ; Blood-brain barrier ; Cirrhosis ; Coma ; Dendritic cells ; Edema ; Electronic health records ; Electronic medical records ; Enzymes ; Hepatic encephalopathy ; Hepatic Encephalopathy - diagnosis ; Hepatic Encephalopathy - epidemiology ; Hepatic Encephalopathy - etiology ; Hepatotoxicity ; Homeostasis ; Humans ; Hyperammonemia ; Hyperammonemia - diagnosis ; Hypertension ; Kidneys ; Laboratories ; Literature reviews ; Liver cirrhosis ; Liver Cirrhosis - diagnosis ; Liver disease ; Liver diseases ; Metabolism ; Musculoskeletal system ; Neurotoxicity ; Neutrophils ; Oxidative stress ; Pathophysiology ; Protein synthesis ; Proteins ; Sarcopenia ; Trends</subject><ispartof>Clinical therapeutics, 2022-03, Vol.44 (3), p.e45-e57</ispartof><rights>2022 Elsevier Ltd</rights><rights>Copyright © 2022 Elsevier Ltd. All rights reserved.</rights><rights>2022. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-4d4a4149dee55d9034ef2576d0528f4dea56ec43e751495d6af5fc64b2c5d5783</citedby><cites>FETCH-LOGICAL-c503t-4d4a4149dee55d9034ef2576d0528f4dea56ec43e751495d6af5fc64b2c5d5783</cites><orcidid>0000-0002-0923-4300</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S014929182200011X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35125217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deutsch-Link, Sasha</creatorcontrib><creatorcontrib>Moon, Andrew M.</creatorcontrib><creatorcontrib>Jiang, Yue</creatorcontrib><creatorcontrib>Barritt, A. Sidney</creatorcontrib><creatorcontrib>Tapper, Elliot B.</creatorcontrib><title>Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends</title><title>Clinical therapeutics</title><addtitle>Clin Ther</addtitle><description>Ammonia is central to the pathophysiology of hepatic encephalopathy (HE) in cirrhosis. Serum ammonia levels have prognostic value and have been implicated in sarcopenia, hepatotoxicity, and immune dysfunction. Studies indicate that clinicians frequently order serum ammonia levels in decompensated cirrhosis; however, the clinical utility of serum ammonia levels has been questioned, citing challenges in accurate measurement and interpretation. This article involves a primary review of the literature to evaluate the importance of serum ammonia in cirrhosis and examines the clinical utility of serum ammonia levels in the management of HE. In addition to the review, we conducted primary research using national claims data to investigate national trends in practitioner use of serum ammonia.
We identified all hospitalizations in a national commercial claims database with and without ammonia testing among adults with noncirrhotic chronic liver disease and cirrhosis from January 1, 2007, to September 31, 2015. We calculated the proportion of hospitalizations with ammonia testing and the number of ammonia tests per 1000 hospital-days.
Proportion of hospitalizations with ammonia testing and ammonia tests per 1000 inpatient-days increased significantly from 2007 to 2015, and particularly in 2014 and 2015, for all groups.
A review of the literature indicated that elevated serum ammonia contributes to neurotoxicity, sarcopenia, and immune dysfunction in cirrhosis. However, serum ammonia testing has not had consistent benefit in clinical diagnosis or management of HE in cirrhosis. Claims data indicated that ammonia testing increased substantially during the study period, particularly after the advent of electronic medical record systems. The rapid increase in testing may suggest that electronic health records play a crucial role in test volume by facilitating easy ordering and could be leveraged to improved value-based serum ammonia ordering. Serum ammonia levels may also benefit from standardized guidelines on collection, laboratory analysis, and interpretation.</description><subject>Adult</subject><subject>Amino acids</subject><subject>Ammonia</subject><subject>Ammonia - analysis</subject><subject>Animal cognition</subject><subject>Blood-brain barrier</subject><subject>Cirrhosis</subject><subject>Coma</subject><subject>Dendritic cells</subject><subject>Edema</subject><subject>Electronic health records</subject><subject>Electronic medical records</subject><subject>Enzymes</subject><subject>Hepatic encephalopathy</subject><subject>Hepatic Encephalopathy - diagnosis</subject><subject>Hepatic Encephalopathy - epidemiology</subject><subject>Hepatic Encephalopathy - etiology</subject><subject>Hepatotoxicity</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Hyperammonemia</subject><subject>Hyperammonemia - diagnosis</subject><subject>Hypertension</subject><subject>Kidneys</subject><subject>Laboratories</subject><subject>Literature reviews</subject><subject>Liver cirrhosis</subject><subject>Liver Cirrhosis - diagnosis</subject><subject>Liver disease</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Musculoskeletal system</subject><subject>Neurotoxicity</subject><subject>Neutrophils</subject><subject>Oxidative stress</subject><subject>Pathophysiology</subject><subject>Protein synthesis</subject><subject>Proteins</subject><subject>Sarcopenia</subject><subject>Trends</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU9v1DAQxS0EokvhK4AlLhyaYDtx_nBAWq0KrVTBga3EzXLtSXdWib3YSaX99nW0y6rlgnyw5PnNvDd-hHzgLOeMV5-3uenRjRsIOhdMiJzxnLHmBVnwpm4zzsvfL8mC8bLNRMubM_Imxi1jrGileE3OCsmFFLxeEPcLwjTQ5TB4h5qioysMYeMjxi90lTTQ6J5eDzttRuo7erXfJc2ZhgH1Bb0dscdxP5fWEEd09xdUO0t_6BG9S63HV7oO4Gx8S151uo_w7nifk9tvl-vVVXbz8_v1anmTGcmKMSttqctk3gJIaVtWlNAJWVeWSdF0pQUtKzBlAbVMlLSV7mRnqvJOGGll3RTn5Oth7m66G8AacGPQvdoFHHTYK69RPa843Kh7_6BaJlkrZBrw6Tgg-D9T2kENGA30vXbgp6hElY6oWTNrffwH3foppN1nShbJN2t4ouoDZYKPMUB3MsOZmjNVW3XKVM2ZKsZVyjR1vn-6y6nvb4gJWB4ASD_6gBBUNAjOgMUAZlTW439FHgF4IrhH</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Deutsch-Link, Sasha</creator><creator>Moon, Andrew M.</creator><creator>Jiang, Yue</creator><creator>Barritt, A. Sidney</creator><creator>Tapper, Elliot B.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0923-4300</orcidid></search><sort><creationdate>20220301</creationdate><title>Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends</title><author>Deutsch-Link, Sasha ; Moon, Andrew M. ; Jiang, Yue ; Barritt, A. Sidney ; Tapper, Elliot B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-4d4a4149dee55d9034ef2576d0528f4dea56ec43e751495d6af5fc64b2c5d5783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Amino acids</topic><topic>Ammonia</topic><topic>Ammonia - analysis</topic><topic>Animal cognition</topic><topic>Blood-brain barrier</topic><topic>Cirrhosis</topic><topic>Coma</topic><topic>Dendritic cells</topic><topic>Edema</topic><topic>Electronic health records</topic><topic>Electronic medical records</topic><topic>Enzymes</topic><topic>Hepatic encephalopathy</topic><topic>Hepatic Encephalopathy - diagnosis</topic><topic>Hepatic Encephalopathy - epidemiology</topic><topic>Hepatic Encephalopathy - etiology</topic><topic>Hepatotoxicity</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Hyperammonemia</topic><topic>Hyperammonemia - diagnosis</topic><topic>Hypertension</topic><topic>Kidneys</topic><topic>Laboratories</topic><topic>Literature reviews</topic><topic>Liver cirrhosis</topic><topic>Liver Cirrhosis - diagnosis</topic><topic>Liver disease</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Musculoskeletal system</topic><topic>Neurotoxicity</topic><topic>Neutrophils</topic><topic>Oxidative stress</topic><topic>Pathophysiology</topic><topic>Protein synthesis</topic><topic>Proteins</topic><topic>Sarcopenia</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deutsch-Link, Sasha</creatorcontrib><creatorcontrib>Moon, Andrew M.</creatorcontrib><creatorcontrib>Jiang, Yue</creatorcontrib><creatorcontrib>Barritt, A. Sidney</creatorcontrib><creatorcontrib>Tapper, Elliot B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deutsch-Link, Sasha</au><au>Moon, Andrew M.</au><au>Jiang, Yue</au><au>Barritt, A. Sidney</au><au>Tapper, Elliot B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends</atitle><jtitle>Clinical therapeutics</jtitle><addtitle>Clin Ther</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>44</volume><issue>3</issue><spage>e45</spage><epage>e57</epage><pages>e45-e57</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Ammonia is central to the pathophysiology of hepatic encephalopathy (HE) in cirrhosis. Serum ammonia levels have prognostic value and have been implicated in sarcopenia, hepatotoxicity, and immune dysfunction. Studies indicate that clinicians frequently order serum ammonia levels in decompensated cirrhosis; however, the clinical utility of serum ammonia levels has been questioned, citing challenges in accurate measurement and interpretation. This article involves a primary review of the literature to evaluate the importance of serum ammonia in cirrhosis and examines the clinical utility of serum ammonia levels in the management of HE. In addition to the review, we conducted primary research using national claims data to investigate national trends in practitioner use of serum ammonia.
We identified all hospitalizations in a national commercial claims database with and without ammonia testing among adults with noncirrhotic chronic liver disease and cirrhosis from January 1, 2007, to September 31, 2015. We calculated the proportion of hospitalizations with ammonia testing and the number of ammonia tests per 1000 hospital-days.
Proportion of hospitalizations with ammonia testing and ammonia tests per 1000 inpatient-days increased significantly from 2007 to 2015, and particularly in 2014 and 2015, for all groups.
A review of the literature indicated that elevated serum ammonia contributes to neurotoxicity, sarcopenia, and immune dysfunction in cirrhosis. However, serum ammonia testing has not had consistent benefit in clinical diagnosis or management of HE in cirrhosis. Claims data indicated that ammonia testing increased substantially during the study period, particularly after the advent of electronic medical record systems. The rapid increase in testing may suggest that electronic health records play a crucial role in test volume by facilitating easy ordering and could be leveraged to improved value-based serum ammonia ordering. Serum ammonia levels may also benefit from standardized guidelines on collection, laboratory analysis, and interpretation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35125217</pmid><doi>10.1016/j.clinthera.2022.01.008</doi><orcidid>https://orcid.org/0000-0002-0923-4300</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-2918 |
ispartof | Clinical therapeutics, 2022-03, Vol.44 (3), p.e45-e57 |
issn | 0149-2918 1879-114X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9050925 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Amino acids Ammonia Ammonia - analysis Animal cognition Blood-brain barrier Cirrhosis Coma Dendritic cells Edema Electronic health records Electronic medical records Enzymes Hepatic encephalopathy Hepatic Encephalopathy - diagnosis Hepatic Encephalopathy - epidemiology Hepatic Encephalopathy - etiology Hepatotoxicity Homeostasis Humans Hyperammonemia Hyperammonemia - diagnosis Hypertension Kidneys Laboratories Literature reviews Liver cirrhosis Liver Cirrhosis - diagnosis Liver disease Liver diseases Metabolism Musculoskeletal system Neurotoxicity Neutrophils Oxidative stress Pathophysiology Protein synthesis Proteins Sarcopenia Trends |
title | Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20Ammonia%20in%20Cirrhosis:%20Clinical%20Impact%20of%20Hyperammonemia,%20Utility%20of%20Testing,%20and%20National%20Testing%20Trends&rft.jtitle=Clinical%20therapeutics&rft.au=Deutsch-Link,%20Sasha&rft.date=2022-03-01&rft.volume=44&rft.issue=3&rft.spage=e45&rft.epage=e57&rft.pages=e45-e57&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2022.01.008&rft_dat=%3Cproquest_pubme%3E2653257081%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2653257081&rft_id=info:pmid/35125217&rft_els_id=S014929182200011X&rfr_iscdi=true |